Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on April 24, 2025
Finance Denmark sélectionne SurePay pour fournir le service national de la Verification Of Payee au Danemark
GlobeNewswire
·
April 24, 2025
UTRECHT, Pays-Bas et COPENHAGUE, Danemark, 24 avr. 2025 (GLOBE NEWSWIRE) -- Finance Denmark, l'association représentant les banques, les établissements hypothécaires et les sociétés financières au Danemark, a choisi SurePay pour fournir un service national …
Finance Denmark kiest SurePay voor Verification Of Payee
GlobeNewswire
·
April 24, 2025
KOPENHAGEN, Denemarken en UTRECHT, Nederland, April 24, 2025 (GLOBE NEWSWIRE) -- Finance Denmark, de associatie van Deense banken, heeft SurePay geselecteerd als leverancier voor Verification Of Payee (VOP). De keuze maakt SurePay verantwoordelijk voor …
Omnea Named “Best Overall eProcurement Software” in 2025 FinTech Breakthrough Awards Program
GlobeNewswire
·
April 24, 2025
LONDON, April 24, 2025 (GLOBE NEWSWIRE) -- FinTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global FinTech market, today announced that Omnea, the procurement intake …
Bioxodes announces positive Phase 2a interim data for BIOX-101 in intracerebral hemorrhagic stroke patients
GlobeNewswire
·
April 24, 2025
Primary endpoint met, no drug-related serious adverse events Positive hematoma and edema volume evolution Recruitment stopped early due to positive exploratory and efficacy outcomes Preparations underway to initiate Phase 2b study Gosselies, Belgium, 24 …
Bioxodes annonce des données intermédiaires positives pour son essai de phase 2a portant sur BIOX-101 dans le traitement de l’AVC hémorragique
GlobeNewswire
·
April 24, 2025
Le critère d’évaluation principal a été atteint, aucun événement indésirable grave associé au médicament n’a été rapporté L’évolution du volume de l’hématome et de l’œdème est favorable Le recrutement des patients a été arrêté plus tôt que prévu en raison …
Late-breaking elafibranor primary sclerosing cholangitis (PSC) data demonstrates favorable safety profile and significant efficacy in second potential rare liver disease indication
GlobeNewswire
·
April 24, 2025
Elafibranor showed a favorable safety profile and demonstrated dose-dependent efficacy over 12 weeks for people living with PSC, a rare liver disease that currently has no approved treatment options Patients treated with elafibranor versus placebo showed …
Les dernières données sur l’élafibranor démontrent un profil de tolérance favorable et une efficacité significative dans la CSP, une deuxième indication dans les maladies rares du foie
GlobeNewswire
·
April 24, 2025
L’élafibranor a montré un profil de tolérance favorable et a démontré une efficacité en termes de relation dose-effet sur 12 semaines chez des patients atteints de CSP, une maladie rare du foie pour laquelle il n’existe actuellement aucune option de …
Press Release: Sanofi: strong Q1 performance and 2025 guidance confirmed
GlobeNewswire
·
April 24, 2025
Sanofi: strong Q1 performance and 2025 guidance confirmed Paris, April 24, 2025 Q1 sales growth of 9.7% at CER1 and business EPS2 of €1.79 Pharma launches reached sales of €0.8 billion, up 43.8%, driven by ALTUVIIIO Dupixent sales were €3.5 billion, up 20. …
Communiqué de presse : Sanofi : forte performance au T1 et confirmation des perspectives pour 2025
GlobeNewswire
·
April 24, 2025
Sanofi : forte performance au T1 et confirmation des perspectives pour 2025 Paris, le 24 avril 2025 Ventes du T1 en progression de 9,7 % à TCC1 et BNPA2 des activités de 1,79 euro Les ventes des nouveaux lancements pharmaceutiques atteignent 0,8 milliard d …
Starke Verkäufe von Cresemba® (Isavuconazol) in Japan lösen zweite Umsatzmeilensteinzahlung von Asahi Kasei Pharma an Basilea aus
GlobeNewswire
·
April 24, 2025
Allschwil, 24. April 2025 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren Infektionen durch Bakterien oder Pilze erkrankt sind, …
Strong sales for Cresemba® (isavuconazole) in Japan trigger second milestone payment from Asahi Kasei Pharma to Basilea
GlobeNewswire
·
April 24, 2025
Allschwil, Switzerland, April 24, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today that the sales of …
Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes
GlobeNewswire
·
April 24, 2025
Press release – No. 6 / 2025 Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes The Phase 2b ZUPREME-2 trial investigates the efficacy and safety of …
Addex Therapeutics to Release Full-Year 2024 Financial Results and Host Conference Call on April 25, 2025
GlobeNewswire
·
April 24, 2025
Geneva, Switzerland, April 24, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that it will …
Verses AI Inc Announces Pricing of Public Offering of Units
GlobeNewswire
·
April 24, 2025
VANCOUVER, British Columbia, April 24, 2025 (GLOBE NEWSWIRE) -- Verses AI Inc. (CBOE: VERS) (OTCQB: VRSSD) (“Verses” or the “Company”) is pleased to announce the pricing of its previously announced public offering (the “Offering”), of 2,750,000 units of …
Snail, Inc. 独立品牌 Wandering Wizards 获 Whispers of West Grove 发行权
GlobeNewswire
·
April 24, 2025
卡尔弗城，加利福尼亚州, April 24, 2025 (GLOBE NEWSWIRE) -- 作为全球领先的互动数字娱乐领域独立开发和发行商，Snail, Inc. (Nasdaq: SNAL，以下简称“Snail Games”或“公司”) 正式宣布，其旗下独立游戏发行部门 Wandering Wizard 已获得 Whispers of West Grove 的发行权，这是一款由 NVNT 工作室开发且即将推出的心理惊悚类恐游。 该游戏将在 Steam 发布，扩大了 Wandering Wizard …
Snail, Inc. 旗下獨立遊戲商 Wandering Wizards 獲《Whispers of West Grove》出版權
GlobeNewswire
·
April 24, 2025
卡爾弗城，加州, April 24, 2025 (GLOBE NEWSWIRE) -- 全球領先的互動數碼娛樂獨立開發商和發行商 Snail, Inc. (Nasdaq: Snal) (「Snail Games」或「公司」)，正式宣布其獨立發行商 Wandering Wizard 已獲由 NVNT Studios 開發、即將推出的心理恐怖遊戲《Whispers of West Grove》的出版權。 該遊戲將在 Steam 上發行，擴展了 Wandering Wizard …
THE BANCORP SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against The Bancorp, Inc. - TBBK
GlobeNewswire
·
April 24, 2025
NEW ORLEANS, April 23, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 16, 2025 to file lead plaintiff applications in a securities class action lawsuit against The Bancorp, Inc. (“ …
E.L.F. BEAUTY SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against e.l.f. Beauty, Inc. - ELF
GlobeNewswire
·
April 24, 2025
NEW ORLEANS, April 23, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 5, 2025 to file lead plaintiff applications in securities class action lawsuits against e.l.f. Beauty, Inc. (“ …
NET POWER SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NET Power Inc. - NPWR
GlobeNewswire
·
April 24, 2025
NEW ORLEANS, April 23, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 17, 2025 to file lead plaintiff applications in a securities class action lawsuit against NET Power Inc. ("Net …
APPLOVIN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against AppLovin Corporation - APP
GlobeNewswire
·
April 24, 2025
NEW ORLEANS, April 23, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 5, 2025 to file lead plaintiff applications in securities class action lawsuits against AppLovin Corporation ( …